Skip to Main Content

Paper Details

Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
J Thromb Haemost
1
2022
PAD, Rivaroxaban, Vascular disease, arterial and venous thrombotic events, arterial or venous thrombotic event, aspirin, non-thrombotic deaths, patient, patients, peripheral arterial disease, peripheral artery disease, rivaroxaban, thrombotic
Author NameAffiliation
Manesh R PatelDuke Clinical Research Institute
Manesh R PatelDuke University Medical Center
Sonia S AnandMcMaster University
Sonia S AnandPopulation Health Research Institute, Hamilton Health Sciences and McMaster University
  • 1 - 4

Datasets

Release 1.2